Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$20.10 USD
-0.11 (-0.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $20.11 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum A VGM
Income Statements
Fiscal Year end for Fresenius Medical Care AG & Co KGaA falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 21,055 | 20,438 | 20,845 | 20,400 | 19,574 |
Cost Of Goods | 15,724 | 14,843 | 14,838 | 14,075 | 13,530 |
Gross Profit | 5,330 | 5,595 | 6,007 | 6,325 | 6,043 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,848 | 4,002 | 3,815 | 3,693 | 3,501 |
Income After Depreciation & Amortization | 1,482 | 1,593 | 2,191 | 2,632 | 2,542 |
Non-Operating Income | 95 | 71 | 87 | 48 | 69 |
Interest Expense | 460 | 379 | 418 | 468 | 550 |
Pretax Income | 1,118 | 1,285 | 1,860 | 2,212 | 2,061 |
Income Taxes | 325 | 342 | 417 | 572 | 450 |
Minority Interest | 253 | 233 | 295 | 310 | 268 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 793 | 942 | 1,442 | 1,640 | 1,611 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 540 | 710 | 1,147 | 1,330 | 1,344 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 3,378 | 3,530 | 4,112 | 4,672 | 4,326 |
Depreciation & Amortization (Cash Flow) | 1,896 | 1,937 | 1,921 | 2,040 | 1,784 |
Income After Depreciation & Amortization | 1,482 | 1,593 | 2,191 | 2,632 | 2,542 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 586.83 | 586.49 | 585.89 | 588.11 | 605.38 |
Diluted EPS Before Non-Recurring Items | 1.39 | 1.64 | 2.06 | 2.64 | 2.53 |
Diluted Net EPS (GAAP) | 0.92 | 1.21 | 1.96 | 2.26 | 2.22 |
Fiscal Year end for Fresenius Medical Care AG & Co KGaA falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 5,371.06 | 5,372.60 | 5,261.48 | 5,049.51 |
Cost Of Goods | NA | 3,917.30 | 4,034.96 | 3,956.04 | 3,816.02 |
Gross Profit | NA | 1,453.77 | 1,337.64 | 1,305.44 | 1,233.49 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 993.47 | 984.75 | 916.57 | 953.40 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 460.30 | 352.89 | 388.87 | 280.09 |
Non-Operating Income | NA | 28.84 | 27.36 | 26.31 | 12.97 |
Interest Expense | NA | 119.93 | 123.92 | 114.14 | 101.60 |
Pretax Income | NA | 369.20 | 256.33 | 301.04 | 191.46 |
Income Taxes | NA | 92.77 | 96.27 | 88.47 | 47.78 |
Minority Interest | NA | 73.92 | 68.25 | 59.52 | 50.98 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 276.43 | 160.06 | 212.57 | 143.68 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 202.51 | 91.81 | 153.05 | 92.70 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 586.83 | 586.83 | 586.83 | 586.83 |
Diluted EPS Before Non-Recurring Items | NA | 0.47 | 0.31 | 0.32 | 0.28 |
Diluted Net EPS (GAAP) | NA | 0.34 | 0.16 | 0.26 | 0.16 |